Stroke at dialysis commencement | p-value (stroke at dialysis commencement v no stroke at dialysis commencement) | ||
---|---|---|---|
No N = 531 | Yes N = 48 | ||
Characteristics at Dialysis Initiation | |||
Age | 64 (51–74) | 68 (56.5–73.5) | 0.141 |
Male Gender | 344 (64.8%) | 38 (79.2%) | 0.044 |
Living Alone | 93 (17.5%) | 8 (16.7%) | 0.878 |
Widowed | 46 (8.7%) | 6 (12.5%) | 0.568 |
Ethnic Group | |||
Caucasian | 497 (93.6%) | 46 (95.8%) | 0.930 |
Primary renal disease | |||
Renovascular Disease/Hypertension | 106 (20.0%) | 17 (35.4%) | 0.012 |
Diabetic kidney disease | 132 (24.9%) | 12 (25.0%) | 0.983 |
Glomerulonephritis/Vasculitis | 104 (19.6%) | 4 (8.3%) | 0.055 |
Pyelonephritis | 30 (5.6%) | 2 (4.2%) | 0.667 |
Autosomal dominant Polycystic Kidney Disease | 65 (12.2%) | 5 (10.4%) | 0.710 |
Other/Unknown | 94 (17.7%) | 8 (16.7%) | 0.857 |
Smoking History | 351 (74.1%) | 34 (75.6%) | 0.826 |
Diabetes | 195 (36.7%) | 20 (41.7%) | 0.497 |
Heart Failure | 74 (13.9%) | 7 (14.6%) | 0.901 |
Myocardial infarction | 78 (14.7%) | 8 (16.7%) | 0.712 |
Peripheral vascular disease | 117 (22.0%) | 8 (16.7%) | 0.387 |
Atrial fibrillation | 59 (11.1%) | 6 (12.5%) | 0.028 |
Haemodialysis as first dialysis modality | 347 (65.3%) | 32 (66.7%) | 0.854 |
Outcomes | |||
Non-Fatal Stroke | 23 (4.3%) | 0 | |
Death from stroke | 4 (2.9%) | 0 | |
Non-Fatal Myocardial infarction | 58 (10.9%) | 4 (8.3%) | 0.578 |
Death from acute myocardial infarctiona | 24 (17.6%) | 4 (25%) | 0.498 |
Death from cardiovascular diseaseb | 50 (36.8%) | 6 (37.5%) | 0.954 |
Newly identified Atrial Fibrillationc | 28 (5.9%) | 1 (2.4%) | 0.303 |
Transplanted | 157 (29.6%) | 10 (20.8%) | 0.198 |
Time from dialysis to transplant (months) | 23 (8–38) | 28 (20–37) | 0.336 |
All-cause mortality | 259 (48.8%) | 31 (64.6%) | 0.036 |
Time from dialysis to death (months) | 28 (12–52) | 16 (6–39) | 0.093 |
Age at death (years) | 74 (64–78) | 72 (64–77) | 0.648 |
Months of follow up from dialysis initiationd | 25 (10–47) | 20 (9–38) | 0.303 |